• Je něco špatně v tomto záznamu ?

Lack of Conserved miRNA Deregulation in HPV-Induced Squamous Cell Carcinomas

J. Nunvar, L. Pagacova, Z. Vojtechova, NTD. Azevedo, J. Smahelova, M. Salakova, R. Tachezy

. 2021 ; 11 (5) : . [pub] 20210520

Jazyk angličtina Země Švýcarsko

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc21025730

Grantová podpora
GA UK No. 80318 Univerzita Karlova v Praze
CZ.02.1.01/0.0/0.0/16_019/0000785 European Regional Development Fund and Ministry of Education, Youth and Sports of the Czech Republic

Squamous cell carcinomas (SCCs) in the anogenital and head and neck regions are associated with high-risk types of human papillomaviruses (HR-HPV). Deregulation of miRNA expression is an important contributor to carcinogenesis. This study aimed to pinpoint commonly and uniquely deregulated miRNAs in cervical, anal, vulvar, and tonsillar tumors of viral or non-viral etiology, searching for a common set of deregulated miRNAs linked to HPV-induced carcinogenesis. RNA was extracted from tumors and nonmalignant tissues from the same locations. The miRNA expression level was determined by next-generation sequencing. Differential expression of miRNAs was calculated, and the patterns of miRNA deregulation were compared between tumors. The total of deregulated miRNAs varied between tumors of different locations by two orders of magnitude, ranging from 1 to 282. The deregulated miRNA pool was largely tumor-specific. In tumors of the same location, a low proportion of miRNAs were exclusively deregulated and no deregulated miRNA was shared by all four types of HPV-positive tumors. The most significant overlap of deregulated miRNAs was found between tumors which differed in location and HPV status (HPV-positive cervical tumors vs. HPV-negative vulvar tumors). Our results imply that HPV infection does not elicit a conserved miRNA deregulation in SCCs.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc21025730
003      
CZ-PrNML
005      
20211026133549.0
007      
ta
008      
211013s2021 sz f 000 0|eng||
009      
AR
024    7_
$a 10.3390/biom11050764 $2 doi
035    __
$a (PubMed)34065237
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a sz
100    1_
$a Nunvar, Jaroslav $u Department of Genetics and Microbiology, Faculty of Science, Charles University, 12844 Prague, Czech Republic $u BIOCEV-Biotechnology and Biomedicine Centre of the Academy of Sciences and Charles University, 25250 Vestec, Czech Republic
245    10
$a Lack of Conserved miRNA Deregulation in HPV-Induced Squamous Cell Carcinomas / $c J. Nunvar, L. Pagacova, Z. Vojtechova, NTD. Azevedo, J. Smahelova, M. Salakova, R. Tachezy
520    9_
$a Squamous cell carcinomas (SCCs) in the anogenital and head and neck regions are associated with high-risk types of human papillomaviruses (HR-HPV). Deregulation of miRNA expression is an important contributor to carcinogenesis. This study aimed to pinpoint commonly and uniquely deregulated miRNAs in cervical, anal, vulvar, and tonsillar tumors of viral or non-viral etiology, searching for a common set of deregulated miRNAs linked to HPV-induced carcinogenesis. RNA was extracted from tumors and nonmalignant tissues from the same locations. The miRNA expression level was determined by next-generation sequencing. Differential expression of miRNAs was calculated, and the patterns of miRNA deregulation were compared between tumors. The total of deregulated miRNAs varied between tumors of different locations by two orders of magnitude, ranging from 1 to 282. The deregulated miRNA pool was largely tumor-specific. In tumors of the same location, a low proportion of miRNAs were exclusively deregulated and no deregulated miRNA was shared by all four types of HPV-positive tumors. The most significant overlap of deregulated miRNAs was found between tumors which differed in location and HPV status (HPV-positive cervical tumors vs. HPV-negative vulvar tumors). Our results imply that HPV infection does not elicit a conserved miRNA deregulation in SCCs.
650    _2
$a nádory anu $x genetika $x virologie $7 D001005
650    _2
$a spinocelulární karcinom $x genetika $x virologie $7 D002294
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a regulace genové exprese u nádorů $7 D015972
650    _2
$a vysoce účinné nukleotidové sekvenování $7 D059014
650    _2
$a lidé $7 D006801
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a mikro RNA $x genetika $7 D035683
650    _2
$a orgánová specificita $7 D009928
650    _2
$a infekce papilomavirem $x genetika $7 D030361
650    _2
$a sekvenční analýza RNA $7 D017423
650    _2
$a tonzilární nádory $x genetika $x virologie $7 D014067
650    _2
$a urogenitální nádory $x genetika $x virologie $7 D014565
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Pagacova, Lucie $u Department of Genetics and Microbiology, Faculty of Science, Charles University, 12844 Prague, Czech Republic $u BIOCEV-Biotechnology and Biomedicine Centre of the Academy of Sciences and Charles University, 25250 Vestec, Czech Republic
700    1_
$a Vojtechova, Zuzana $u Department of Genetics and Microbiology, Faculty of Science, Charles University, 12844 Prague, Czech Republic $u BIOCEV-Biotechnology and Biomedicine Centre of the Academy of Sciences and Charles University, 25250 Vestec, Czech Republic
700    1_
$a Azevedo, Nayara Trevisan Doimo de $u Genomics Core Facility, EMBL, 69117 Heidelberg, Germany
700    1_
$a Smahelova, Jana $u Department of Genetics and Microbiology, Faculty of Science, Charles University, 12844 Prague, Czech Republic $u BIOCEV-Biotechnology and Biomedicine Centre of the Academy of Sciences and Charles University, 25250 Vestec, Czech Republic
700    1_
$a Salakova, Martina $u Department of Genetics and Microbiology, Faculty of Science, Charles University, 12844 Prague, Czech Republic $u BIOCEV-Biotechnology and Biomedicine Centre of the Academy of Sciences and Charles University, 25250 Vestec, Czech Republic
700    1_
$a Tachezy, Ruth $u Department of Genetics and Microbiology, Faculty of Science, Charles University, 12844 Prague, Czech Republic $u BIOCEV-Biotechnology and Biomedicine Centre of the Academy of Sciences and Charles University, 25250 Vestec, Czech Republic
773    0_
$w MED00188737 $t Biomolecules $x 2218-273X $g Roč. 11, č. 5 (2021)
856    41
$u https://pubmed.ncbi.nlm.nih.gov/34065237 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20211013 $b ABA008
991    __
$a 20211026133555 $b ABA008
999    __
$a ok $b bmc $g 1714665 $s 1146237
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2021 $b 11 $c 5 $e 20210520 $i 2218-273X $m Biomolecules $n Biomolecules $x MED00188737
GRA    __
$a GA UK No. 80318 $p Univerzita Karlova v Praze
GRA    __
$a CZ.02.1.01/0.0/0.0/16_019/0000785 $p European Regional Development Fund and Ministry of Education, Youth and Sports of the Czech Republic
LZP    __
$a Pubmed-20211013

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...